LUMOS PHARMA, INC. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LUMOS PHARMA, INC. for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23 2018 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Payment of Exercise | F | 8.62 | 85 | 733 | 13,892 | 14 K to 13.9 K (-0.61 %) |
| Jan 05 2018 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Payment of Exercise | F | 10.06 | 409 | 4,115 | 13,977 | 14.4 K to 14 K (-2.84 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 10.06 | 1,323 | 13,309 | 57,536 | 58.9 K to 57.5 K (-2.25 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 8.47 | 164 | 1,389 | 58,859 | 59 K to 58.9 K (-0.28 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Payment of Exercise | F | 10.06 | 257 | 2,585 | 18,905 | 19.2 K to 18.9 K (-1.34 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Payment of Exercise | F | 8.47 | 883 | 7,479 | 19,162 | 20 K to 19.2 K (-4.41 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 10.06 | 5,541 | 55,742 | 259,842 | 265.4 K to 259.8 K (-2.09 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 8.47 | 8,939 | 75,713 | 265,383 | 274.3 K to 265.4 K (-3.26 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 10.06 | 603 | 6,066 | 18,150 | 18.8 K to 18.2 K (-3.22 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 8.47 | 1,237 | 10,477 | 18,753 | 20 K to 18.8 K (-6.19 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 10.06 | 2,659 | 26,750 | 53,408 | 56.1 K to 53.4 K (-4.74 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 8.47 | 3,866 | 32,745 | 56,067 | 59.9 K to 56.1 K (-6.45 %) |